ClinicalTrials.gov
ClinicalTrials.gov Menu

Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00248027
Recruitment Status : Terminated
First Posted : November 3, 2005
Last Update Posted : September 13, 2006
Sponsor:
Information provided by:
McMaster University

Brief Summary:

Main Research questions:

  1. Who are the patients referred for treatment at the Psychotic Disorders Clinic?
  2. What are the outcomes from treatment for first episode psychosis in multiple outcome domains?
  3. What hospital resources are used over the early course of the illness?
  4. How satisfied are patients and family with the treatment and services they received? This is an important study that will help us evaluate the service and treatment offered by the Psychotic Disorders Clinic's specialized early intervention program,which helps young people experiencing early stages of psychotic illness.A growing body of evidence suggests that intervening earlier in the course of the illness with specialized and complimentary pharmacological and psychosocial treatment may be associated with improved outcomes.

Condition or disease
Schizophreniform,First Episode Psychosis

Detailed Description:

The project is primarily a descriptive study of individuals experiencing their first episode of psychosis presenting at the Psychotic Disorders Clinic/Early Intervention Program.

The objectives of the study are:

  1. Track multi-dimensional outcomes within the program
  2. Track service use
  3. Compare outcomes for this early intervention program with outcomes noted in published follow up studies
  4. Evaluate effectiveness of the Psychotic Disorders Clinic in improving outcomes for persons experiencing their first episode of psychosis

Study Type : Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic
Study Start Date : January 2004

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • male or female between ages of 16 to 50 years of age
  • capable of providing informed consent
  • receiving treatment voluntarily
  • experiencing a "first episode of psychosis" defined as the first episode of illness and where the subject,at presentation,meets DSM-IV criteria for one of the following diagnoses:schizophrenia,schizophreniform disorder,schizoaffective disorder,brief psychotic disorder,delusional disorder,and psychosis NOS

Exclusion Criteria:

  • primary diagnosis of mood disorder
  • diagnosis of substance-induced psychosis
  • diagnosis of psychosis due to a general medical condition
  • diagnosis of mental retardation
  • diagnosis of developmental disorder
  • has received antipsychotic treatment for greater than 1 month
  • has received treatment for an earlier episode of psychosis from which there has been a remission of symptoms for greater than 3 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00248027


Locations
Canada, Ontario
Cleghorn Program-Early Intervention in Psychosis.St Joseph's Healthcare Hamilton/Hamilton Health Sciences
Hamilton, Ontario, Canada, L8N 1Y2
Sponsors and Collaborators
Hamilton Health Sciences Corporation
Investigators
Principal Investigator: Suzanne Archie, MD,FRCP(C) Assistant Professor Dept of Psychiatry and Behavioural Neurosciences McMaster University.Active Medical Staff Hamilton Health Sciences.Clinical Director of Cleghorn Early Intervention in Psychosis Program and Psychotic Disorders Clinic

ClinicalTrials.gov Identifier: NCT00248027     History of Changes
Other Study ID Numbers: REB #04-203
First Posted: November 3, 2005    Key Record Dates
Last Update Posted: September 13, 2006
Last Verified: September 2006

Keywords provided by McMaster University:
early intervention,program evaluation

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders